Backlinks
| Referring page | DR | Ref. domains | Linked domains | Anchor and target URL |
|---|---|---|---|---|
|
Biopolymer Cancer Vaccine Technology | Inpart
https://app.in-part.com/login-preview?returnTo=/opportunities/db36b7fb-3adc-468c-93cf-69586e4c7a51
app.in-part.com
|
50 | 7 | 3 |
(no anchor)
https://in-part.com/
DOFOLLOW
|
|
Für Wissenschaftler | ScienceValue Heidelberg
https://www.sciencevalue-heidelberg.de/fuer-wissenschaftler
sciencevalue-heidelberg.de
|
48 | 2 | 3 |
IN-PART
https://in-part.com/
DOFOLLOW
|
|
GRP8 as a Target for Improving Plant Stress Response to Water and Nutrient St...
https://app.in-part.com/login-preview?returnTo=/opportunities/f389901b-9f70-4f32-b3a3-077f16570160?utm_source=labiotech.eu&utm_campaign=labiotech_integration_articles&utm_content=climate_crops&utm_medium=referral
app.in-part.com
|
50 | 7 | 3 |
(no anchor)
https://in-part.com/
DOFOLLOW
|
|
Unlocking Axonal Repair: Targeting Neutrophil NETs to Accelerate Peripheral N...
https://app.in-part.com/login-preview?returnTo=/opportunities/eba12a3e-ee42-47ce-a758-9f0ebb07466e?utm_source=technologies&utm_content={"search":["Hokkaido"]}&utm_medium=app&utm_term=search
app.in-part.com
|
50 | 7 | 3 |
(no anchor)
https://in-part.com/
DOFOLLOW
|
|
Enhanced RNAi Potency | Inpart
https://app.in-part.com/login-preview?returnTo=/opportunities/defd310c-ffea-44d9-ad92-fa4fb48dfa02&utm_campaign=Labiotech_Connect&utm_medium=referral&utm_source=labiotech.eu
app.in-part.com
|
50 | 7 | 3 |
(no anchor)
https://in-part.com/
DOFOLLOW
|
|
Novel Toll-Like Receptor (TLR) 7/8 Agonist Antibody-Drug Conjugates | Inpart
https://app.in-part.com/login-preview?returnTo=/opportunities/77b84665-0bc4-4f10-aedb-2b5ca4c8ad4c?utm_source=labiotech.eu&utm_campaign=labiotech_integration_articles&utm_content=tlr_agonist_review&utm_medium=referral
app.in-part.com
|
50 | 7 | 3 |
(no anchor)
https://in-part.com/
DOFOLLOW
|
|
Narcolepsy Type-I Vaccine | Inpart
https://app.in-part.com/login-preview?returnTo=/opportunities/c932c906-661a-4ad5-80f3-89c64b9470b2?utm_source=labiotech.eu&utm_campaign=labiotech_integration_articles&utm_content=narcolepsy_treatment&utm_medium=referral
app.in-part.com
|
50 | 7 | 3 |
(no anchor)
https://in-part.com/
DOFOLLOW
|
|
Tumor Mitochondria Vaccine for the Treatment of Cancer | Inpart
app.in-part.com
|
50 | 7 | 3 |
(no anchor)
https://in-part.com/
DOFOLLOW
|
|
Natural Treatment for Inflammatory Bowel Disease (IBS) | Inpart
https://app.in-part.com/login-preview?returnTo=/opportunities/f089888a-ebb4-4e8b-960c-9fe7fb9f9824
app.in-part.com
|
50 | 7 | 3 |
(no anchor)
https://in-part.com/
DOFOLLOW
|
|
COPD Diagnostic Tool | Inpart
https://app.in-part.com/login-preview?returnTo=/opportunities/c191ba80-28ca-45f5-830f-02218a125524
app.in-part.com
|
50 | 7 | 3 |
(no anchor)
https://in-part.com/
DOFOLLOW
|
|
A Novel Mouse Model for the Study of Narcolepsy and Orexin System Function | ...
https://app.in-part.com/login-preview?returnTo=/opportunities/10b8200c-f611-4298-9373-4846706a6a48?utm_source=labiotech.eu&utm_campaign=labiotech_integration_articles&utm_content=narcolepsy_treatment&utm_medium=referral
app.in-part.com
|
50 | 7 | 3 |
(no anchor)
https://in-part.com/
DOFOLLOW
|
|
Inova acquires IN-PART, matchmaking platform for academia-industry collaborat...
https://www.mercia.co.uk/inova-acquires-in-part-matchmaking-platform-for-academia-industry-collaboration
mercia.co.uk
|
61 | 37 | 305 |
IN-PART
https://in-part.com/
DOFOLLOW
|
|
Introducing MakerHub – Sheffield Digital
sheffield.digital
|
65 | 11 | 360 |
IN-PART
https://in-part.com/
DOFOLLOW
|
|
#ComunicaCiencia desde una start-up que conecta industria y academia a través...
https://www.bioblogia.net/2021/10/comunicaciencia-desde-una-start-up-que.html
bioblogia.net
|
6 | 1 | 567 |
We’re looking for an engaged, proactive individual to join our team
https://in-part.com/careers
DOFOLLOW
|
|
Vaccines to Mobilize B Cells for Cancer | Inpart
https://app.in-part.com/login-preview?returnTo=/opportunities/18cd0bec-411d-46bd-8cc3-5ae2c8c1743a
app.in-part.com
|
50 | 7 | 3 |
(no anchor)
https://in-part.com/
DOFOLLOW
|
|
Antibiotic Resistance Platform (ARP) | Inpart
https://app.in-part.com/login-preview?returnTo=/opportunities/23bc82b5-4179-435f-a44d-3487983abbe5?utm_source=opportunity&utm_campaign=copy-link&utm_medium=app&utm_term=header-bar
app.in-part.com
|
50 | 7 | 3 |
(no anchor)
https://in-part.com/
DOFOLLOW
|
|
New spinout Empower Therapeutics sets its sights on reducing pain 'chronifica...
https://www.birmingham.ac.uk/news-archive/2021/new-spinout-empower-therapeutics-sets-its-sights-on-reducing-pain-chronification
birmingham.ac.uk
|
81 | 1,819 | 2,927 |
www.in-part.com
http://www.in-part.com/
DOFOLLOW
|
|
login-preview
https://app.in-part.com/login-preview?returnTo=/opportunities/d50d8b17-df00-4e6e-aa59-33fa4c2ec1d0?utm_source=labiotech.eu&utm_campaign=labiotech_integration_articles&utm_content=breast_cancer_review&utm_medium=referral
app.in-part.com
|
50 | 7 | 3 |
(no anchor)
https://in-part.com/
DOFOLLOW
|
|
Treatment of Parkinson's Disease With an Injectable Hydrogel | Inpart
https://app.in-part.com/login-preview?returnTo=/opportunities/dddda2a5-b725-422b-bd88-7ffd59075177?utm_source=labiotech.eu&utm_campaign=labiotech_integration_articles&utm_content=parkinsons&utm_medium=referral
app.in-part.com
|
50 | 7 | 3 |
(no anchor)
https://in-part.com/
DOFOLLOW
|
|
Can companies buy carbon credits and reduce emissions at the same time?
https://www.senken.io/blog/can-companies-buy-carbon-credits-and-reduce-emissions-at-the-same-time
senken.io
|
65 | 18 | 199 |
- Source
https://in-part.com/blog/addressing-the-next-global-challenge-sustainable-materials-for-a-circular-economy
DOFOLLOW
|
|
A guide to university-industry collaboration for early career researchers - E...
https://ecrcommunity.plos.org/2020/10/23/a-guide-to-university-industry-collaboration-for-early-career-researchers
ecrcommunity.plos.org
|
15 | 12 | 443 |
IN-PART
https://in-part.com/
DOFOLLOW
|
|
3D-printed sweat sensor one of world’s top healthcare innovations in 2023 | U...
https://www.hawaii.edu/news/2023/10/05/sweat-sensor-top-healthcare-innovation
hawaii.edu
|
80 | 1,046 | 1,071 |
IN-PART
https://in-part.com/blog/17-top-healthcare-innovations-2023-identified-by-the-global-rd-community
DOFOLLOW
|
|
Revolutionizing Agriculture: Enhancing Crop Resilience in the Face of Adverse...
https://app.in-part.com/login-preview?returnTo=/opportunities/6502aae3-a057-4f72-b976-d3c8d762d759?utm_source=labiotech.eu&utm_campaign=labiotech_integration_articles&utm_content=climate_crops&utm_medium=referral
app.in-part.com
|
50 | 7 | 3 |
(no anchor)
https://in-part.com/
DOFOLLOW
|
|
Adaptive Immune Response Stimulated with TLR8 and Dual TLR7/TLR8 Agonists | I...
https://app.in-part.com/login-preview?returnTo=/opportunities/5f35c71a-ba65-486f-b794-231a717ec57d?utm_source=labiotech.eu&utm_campaign=labiotech_integration_articles&utm_content=tlr_agonist_review&utm_medium=referral
app.in-part.com
|
50 | 7 | 3 |
(no anchor)
https://in-part.com/
DOFOLLOW
|
|
ASK1 inhibitors as Potential Pan-antiviral Drugs | Inpart
https://app.in-part.com/login-preview?returnTo=/opportunities/8a5fddcd-a856-4b91-b28c-ab1ef12d4382?utm_source=opportunity&utm_campaign=copy-link&utm_medium=app&utm_term=header-bar
app.in-part.com
|
50 | 7 | 3 |
(no anchor)
https://in-part.com/
DOFOLLOW
|
|
Brain Organoid Platform for Parkinson’s Disease Drug Discovery | Inpart
app.in-part.com
|
50 | 7 | 3 |
(no anchor)
https://in-part.com/
DOFOLLOW
|
|
Individualizing Head-Related Transfer Functions Using Smartphones | Inpart
https://app.in-part.com/login-preview?returnTo=/opportunities/12201593-7c1d-48cc-836d-635054b34086?utm_source=opportunity&utm_campaign=copy-link&utm_medium=app&utm_term=header-bar
app.in-part.com
|
50 | 7 | 3 |
(no anchor)
https://in-part.com/
DOFOLLOW
|
|
Novel RNA Therapeutic Delivery to Hepatic Stellate Cells via PDGF-Mediated Up...
https://app.in-part.com/login-preview?returnTo=/opportunities/4ff339f6-97f5-4dbe-a63e-732ec938ce56?utm_source=technologies&utm_content={"search":["Novel RNA Therapeutic Delivery to Hepatic Stellate Cells via PDGF-Mediated Uptake for Liver Fibrosis Therapy"]}&utm_medium=app&utm_term=search
app.in-part.com
|
50 | 7 | 3 |
(no anchor)
https://in-part.com/
DOFOLLOW
|
▾
Frequently Asked Questions
How many backlinks does in-part.com have?
The backlinks page for in-part.com shows all individual inbound links discovered in our crawl of the web. Each backlink represents a hyperlink on another website that points to a page on in-part.com. Use the filters to narrow results by dofollow/nofollow status, domain rating, or anchor text.
What is a backlink?
A backlink is a hyperlink on one website that points to a page on a different website. Backlinks are one of the most important ranking factors in search engine algorithms because they act as votes of confidence from other sites. The more high-quality backlinks a domain has, the more authority search engines assign to it.
Are the backlinks to in-part.com dofollow or nofollow?
Backlinks to in-part.com include both dofollow and nofollow links. Dofollow links pass link equity (ranking power) to the target site, while nofollow links include a rel="nofollow" attribute that tells search engines not to pass authority. Both types contribute to a natural backlink profile, but dofollow links carry more SEO weight. You can filter by link type using the rel filter above the table.
How often is backlink data updated?
Backlink data is updated monthly when our web crawler completes a new cycle. Our pipeline processes billions of web pages to discover new backlinks, track lost links, and update domain authority scores. The freshness of data depends on when our crawler last visited the referring pages.